(Reuters) – Eli Lilly and Co said on Tuesday the U.S. government bought 614,000 additional doses of its COVID-19 antibody therapy for $1.29 billion.
(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D’Silva)
U.S. buys more doses of Lilly’s COVID-19 treatment for $1.29 billion
Nov 2, 2021 | 6:57 AM
